New York, NY -- (SBWIRE) -- 01/17/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Green Innovations Ltd (OTC:GNIN), Opko Health Inc (NYSE:OPK), Zogenix, Inc (NASDAQ:ZGNX), NewLead Holdings Ltd (NASDAQ:NEWL)
Green Innovations Ltd (OTC:GNIN) showed a volume of 2.28 million shares by the end of last trade whereas the average volume of the stock remained 734,973 shares. The stock opened the session at $5.67 but then moved to $5.32. At that price, the stock showed a negative performance of -6.34%. First Bancorp is a bank holding company. The Company is a service provider of financial services and products with operations in Puerto Rico, the United States and the United States and British Virgin Islands. The Company has six segments: Consumer (Retail) Banking; Commercial and Corporate Banking; Mortgage Banking; Treasury and Investments; United States Operations, and Virgin Islands Operations.
Will GNIN Get Buyers Even After The Recent Rally? Find Out Here
Opko Health Inc (NYSE:OPK) opened the session at $8.88 and closed the session at $8.80. The stock showed a negative performance of -0.56% in previous trading session. Traded with volume of 2.23 million shares in the prior session and the average volume of the stock remained 4.89 million shares. OPKO Health, Inc. (OPKO) is a multi-national pharmaceutical and diagnostics company. OPKO is developing a range of solutions to diagnose, treat and prevent various conditions, including molecular diagnostics tests, point-of-care tests, and pharmaceuticals and vaccines.
Has OPK Found The Bottom And Ready To Gain Momentum? Find Out Here
Zogenix, Inc (NASDAQ:ZGNX) opened the session at $4.39 and closed the session at $4.40. The stock showed a positive performance of 0.23% in previous trading session. Traded with volume of 2.23million shares in the prior session and the average volume of the stock remained 2.61 million shares. The beta of the stock remained 2.54. Zogenix, Inc. (Zogenix) is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain. The Company’s product Sumavel DosePro offers needle-free subcutaneous administration of sumatriptan for the treatment of migraine and cluster headache in a pre-filled, single-use delivery system.
Why Should Investors Buy ZGNX After The Recent Gain? Just Go Here and Find Out
NewLead Holdings Ltd (NASDAQ:NEWL) the stock decreased -10.97% and finished the session at $1.38. Traded with volume of 2.22 million shares in the prior session and the average volume of the stock remained 773,531.00 shares. The beta of the stock remained 1.01. NewLead Holdings Ltd. (NewLead) is an international shipping company engaged in the transportation of refined products, such as gasoline and jet fuel, and dry bulk goods, such as iron ore, coal and grain. NewLead operates in two segments: wet operations,
Will NEWL Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)